High prevalence of vitamin D deficiency and its association with metabolic disorders in elderly patients

• Authors: Koziarska-Rościszewska Małgorzata , Rysz Jacek , Stępień Mariusz
• Languages of publication: EN

Keywords

EN

vitamin D deficiency; metabolic disorders; elderly people.

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2017
• Issue: 4
• Pages: 372-376

Contributors

author

Koziarska-Rościszewska Małgorzata

author

Rysz Jacek

author

Stępień Mariusz

References

• Harikrishnan S, Sanjay G. Vitamin D and cardiovascular disease – have we found the answers? Indian Heart J 2015; 67(1): 11–13.
• Marcinowska-Suchowierska E, Walicka M. Niedobór witaminy D – narastający problem społeczny. Fam Med Prim Care Rev 2009; 11(3):691–698 (in Polish).
• Chowdhury R, Stevens S, Ward H, et al. Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur J Epidemiol 2012; 27: 581–591.
• WHO. Obesity [cited 1.06.2017]. Available from UR L: www.who.int/topics/obesity/en.
• International Obesity Task Force. The Global Challenge of Obesity and the International Obesity Task Force [cited 1.06.2016]. Available from UR L: http://www.iuns.org/the-global-challenge-of-obesity-and-the-international-obesity-task-force/.
• Jarosz M, Rychlik E. Otyłość – problem coraz bardziej powszechny. Fam Med Prim Care Rev 2009; 11(3): 647–653 (in Polish).
• Zdrojewski T, Grodzicki T, Więcek A, et al. Aspekty medyczne, psychologiczne, socjologiczne i ekonomiczne starzenia się ludzi w P olsce.Projekt PolSenior [cited 3.06.2016]. Available from UR L: http://polsenior.iimcb.gov.pl/monografia (in Polish).
• Thompson J, Nitiahpapand R, Bhatti P, et al. Vitamin D deficiency and atrial fibrillation. Int J Cardiol 2015; 184C: 159–162.
• Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol 2011; 96(7): 1911–1930.
• Ginde AA , Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 2009; 169(6): 626–632.
• Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013; 10: e1001383, doi: 10.1371/journal.pmed.1001383.
• Song Q, Sergeev IN. Calcium and vitamin D in obesity. Nutr Res Rev 2012; 25: 130–141.
• Martini LA, Wood RJ. Vitamin D status and the metabolic syndrome. Nutr Rev 2006; 64: 479–486
• González L, Ramos-Trautmanna G, Díaz-Luquis GM, et al. Vitamin D status is inversely associated with obesity in a clinic-based sample in Puerto Rico. Nutr Res 2015; 35(4): 287–293.
• GUS . Stan Zdrowia Ludności Polski w 2009 r. [cited 3.06.2016]. Available from UR L: www.stat.gov.pl/cps/rde/xbcr/gus/PU BL_ZO _stan_zdrowia_2009.pdf.
• Stolarczyk A, Horvath A, Szczechura M, et al. High prevalence of vitamin D insufficiency in community-dwelling postmenopausal Polish women. Przegl Menop 2014; 13(5): 289–292.
• Napiórkowska L, Budlewski T, Jakubas-Kwiatkowska W, et al. Prevalence of low serum vitamin D concentration in an urban population of elderly women in Poland. Pol Arch Med Wewn 2009; 119(11): 699–703.
• Prasad P, Kochhar A. Interplay of vitamin D and metabolic syndrome: a review. Diab Met Syndr: Clin Res Rev 2015; 10(2): 105–112, doi:http://dx.doi.org/10.1016/j.dsx.2015.02.014.
• Mandarino NR, Junior DD, Salgano JV, et al. Is vitamin D deficiency a new risk factor for cardiovascular disease? Open Cardiovasc Med J 2015; 9: 40–49.
• Daly RM, Gagnon C, Lu ZX, et al. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older:a national, population-based study. Clin Endocrinol (Oxford) 2012; 77(1): 26–35.
• Guasch A, Bulló M, Rabassa A, et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia:a cross-sectional study. Cardiovasc Diabetol 2012; 11: 149–160.
• Cheng S, Massaro J, Fox C, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham heart study. Diabetes 2010; 59:242–248.
• Carrillo A, Flynn M, Pinkston C, et al. Impact of vitamin D supplementation during a resistance training intervention on body composition,muscle function, and glucose tolerance in overweight and obese adults. Clin Nutr 2013; 32: 375–381.
• Kienreich K, Tomaschitz A, Verheyen N, et al. Vitamin D and cardiovascular disease. Nutrients 2013; 5(8): 3005–3021.
• Pittas AG , Harris SS , Stark PC . The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30: 980–986.
• Tsur A, Feldman B, Feldhammer I, et al. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care 2013; 36(5): 1361–1367.
• George PS , Pearson ER , Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and metaanalysis. Diabetes Med 2012; 29: 142–150.
• Badawi A, Sayegh S, Sadoun E, et al. Relationship between insulin resistance and plasma vitamin D in adults. Diab Met Syndr Obes 2014; 7: 297–313.
• Miñambres I, Sánchez-Quesada JL, Sánchez-Hernández J, et al. Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment. Diabetol Metab Syndr 2014; 6: 7, doi: 10.1186/1758-5996-6-7.
• Ford E, Ajani U, Mcguire L, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 2: 1128–30.
• Pilz S, Gaksch M, Kienreich K, et al. Effects of vitamin D on blood pressure and cardiovascular risk factors. A randomized controlled trial.Hypertension 2015; 65(6): 1195–1201, doi: 10.1161/HYPERTE NSIO NAHA.115.05319.
• Kunutsor SK, Apekey TA , Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 2013; 28: 205–21.
• Wu SH, Ho SC , Zhong L. Effects of vitamin D supplementation on blood pressure. South Med J 2010; 103: 729–737.
• Pankaj A, Song Y, Dusek J, et al. Vitamin D therapy in Individuals with prehypertension or hypertension: the DAY LIG HT trial. Circulation 2015; 131(3): 254–262, doi: 10.1161/CIRCU LATIO NAHA.114.011732.
• Zittermann A, Iodice S, Pilz S, et al. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95: 91–100
• Schottker B, Ball D, Gellert C, et al. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2012; 12: 708–718.
• Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies.Prev Med 2010; 51: 228–233.
• Mathus-Vliegen EM. Obesity and the elderly. J Clin Gastroenterol 2012; 46(7): 533–544.
• Verdoia M, Schaffer A, Barbieri L, et al. Novara Atherosclerosis Study Group (NAS ). Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease. Nutr Metab Cardiovasc Dis 2015, doi: http://dx.doi.org/10.1016/j.numecd.2015.01.009.